Fundraising FoxMohr Davidow Ventures — 2010 Investments
1 investments dated 2010 · listed companies and verified rows first · show all
Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.
BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US
Christophe Schilling(Co-founder (former CEO))inBernhard Palsson(Co-founder)Carlos A. Cabrera(Executive Chairman)inJohn G. Gugel(Chief Executive Officer)inTom McDonald(SVP, Finance & Chief Financial Officer)inNelson Barton(SVP, Research and Development)in
Co-investorsThule InvestmentsVantagePoint Capital PartnersViking GlobalCasdin CapitalDraper Fisher Jurvetson (DFJ)Novo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.